The once-daily device, bioequivalent to the existing prefilled syringe, gives adults with AChR antibody-positive generalized MG a second self-injection option.
|Articles|April 18, 2012
Express Scripts' 2011 Drug Trend Report Is Available Now
Express Scripts recently announced that their new Drug Trend Report is available for download.
Advertisement
The 2011 Drug Trend Report from Express Scripts is now available for download,
Here’s a sneak peek at the topics discussed in the new Drug Trend Report:
- New insights into nonadherence
- Innovative solutions for enhanced patient care
- 2011 industry review
- Changes in prescription drug spending in 2011
- In-depth review of traditional and specialty medications
- Forecast of traditional and specialty medications
- Medicare and Medicaid overview, challenges, solutions, and trends
- Analysis of the top three traditional therapy classes - inflammatory conditions, multiple sclerosis, and cancer
The report is full of tidbits regarding specialty drug trends and forecasts. This is a
Advertisement
Related to this article
In an interview with Pharmacy Times, Ali A. Habib, MD, clinical professor of neurology at the University of California, Irvine, discusses what the hospitalization findings mean for patients and why they should be viewed as supportive evidence
The PD-1 inhibitor is the first immunotherapy approved for stage II and III MSI-H/dMMR locally advanced rectal cancer and may allow eligible patients to avoid chemotherapy, radiation, and surgery.
The once-nightly drop, previously approved to reverse pupil dilation, met its primary end point in 2 phase 3 trials, with conjunctival hyperemia most common.
Public data may help identify drugs associated with shortages, but hospital inventory and purchasing data could make early-warning tools more useful.
Danielle Roman, PharmD, BCOP, FHOPA, explains how ASCO’s updated breast cancer surveillance guideline links follow-up intensity to recurrence risk and creates opportunities for pharmacist involvement.
Pharmacy students can create greater career optionality by viewing the PharmD as a professional platform rather than a predetermined job title.
FDA-approved capivasertib triplet improves rPFS in PTEN-deficient mCSPC; learn dosing, key drug interactions, and managing diarrhea, hyperglycemia, and rash.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Peptide Compounding Is Evolving: What Pharmacists Need to Know Now
2
Dostarlimab Receives FDA Accelerated Approval for MSI-H/dMMR Locally Advanced Rectal Cancer
3
Finerenone in Heart Failure: Evidence and Practice a Year Later
4
FDA Approves Phentolamine Eye Drop for Presbyopia in Adults
5